Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001676629 | SCV001893215 | benign | not provided | 2021-01-25 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002386499 | SCV002668455 | benign | Inborn genetic diseases | 2021-07-13 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV001676629 | SCV004162500 | uncertain significance | not provided | 2022-12-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001676629 | SCV004266110 | benign | not provided | 2022-12-14 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004536249 | SCV004735376 | likely benign | ARID1B-related disorder | 2023-01-30 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |